Danya Salah Baz, Dareen Baz, Fawzah Alrwuili, Abdullah Aldowaish, H. Shamseldin, Ayman Elhomoudi, F. Alkuraya
{"title":"Clinical exome sequencing by general pediatricians: high clinical utility and no evidence of inappropriate testing","authors":"Danya Salah Baz, Dareen Baz, Fawzah Alrwuili, Abdullah Aldowaish, H. Shamseldin, Ayman Elhomoudi, F. Alkuraya","doi":"10.3389/fped.2024.1392444","DOIUrl":null,"url":null,"abstract":"Genetic disorders account for a large percentage of admissions and outpatient visits to children's hospitals around the world. Clinical exome sequencing (CES) is a valuable diagnostic tool in the workup of these disorders; however, it is not routinely requested by general pediatricians. This may represent a missed opportunity to increase patient access to this powerful diagnostic tool. In our institution, general pediatricians can directly order CES. In this context, this study aims to evaluate the appropriateness of CES and its clinical utility when ordered by general pediatricians.We retrospectively reviewed all CES tests ordered by general pediatricians in our institution between 2019 and 2023 and recorded their indications and results. General pediatricians were interviewed to evaluate how CES impacted the domains of clinical utility by assessing changes in management, communication, subsequent testing, and counseling. In addition, feedback was obtained, and barriers faced by general pediatricians to order CES were assessed.The study cohort (n = 30) included children from the inpatient (60%) and outpatient (40%) departments. A positive finding (a pathogenic or likely pathogenic variant that explains the phenotype) was observed in 11 of 30 cases (37%), while 3 (10%) and 16 (53%) received ambiguous (variant of uncertain significance) and negative results, respectively. The indication was deemed appropriate in all 30 cases (100%). Clinical utility was reported in all 11 positive cases (100%). Reproductive counseling is a notable utility in this highly consanguineous population, as all variants identified, in the 11 positive cases, were autosomal recessive.We show that CES ordered by general pediatricians is appropriately indicated and provides a diagnostic yield comparable to that requested by specialists. In addition, we note the high clinical utility of positive results as judged by the ordering pediatricians. The findings of this study can empower general pediatricians to advocate for expanded CES adoption to improve patient access and shorten their diagnostic odyssey.","PeriodicalId":510143,"journal":{"name":"Frontiers in Pediatrics","volume":"12 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fped.2024.1392444","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Genetic disorders account for a large percentage of admissions and outpatient visits to children's hospitals around the world. Clinical exome sequencing (CES) is a valuable diagnostic tool in the workup of these disorders; however, it is not routinely requested by general pediatricians. This may represent a missed opportunity to increase patient access to this powerful diagnostic tool. In our institution, general pediatricians can directly order CES. In this context, this study aims to evaluate the appropriateness of CES and its clinical utility when ordered by general pediatricians.We retrospectively reviewed all CES tests ordered by general pediatricians in our institution between 2019 and 2023 and recorded their indications and results. General pediatricians were interviewed to evaluate how CES impacted the domains of clinical utility by assessing changes in management, communication, subsequent testing, and counseling. In addition, feedback was obtained, and barriers faced by general pediatricians to order CES were assessed.The study cohort (n = 30) included children from the inpatient (60%) and outpatient (40%) departments. A positive finding (a pathogenic or likely pathogenic variant that explains the phenotype) was observed in 11 of 30 cases (37%), while 3 (10%) and 16 (53%) received ambiguous (variant of uncertain significance) and negative results, respectively. The indication was deemed appropriate in all 30 cases (100%). Clinical utility was reported in all 11 positive cases (100%). Reproductive counseling is a notable utility in this highly consanguineous population, as all variants identified, in the 11 positive cases, were autosomal recessive.We show that CES ordered by general pediatricians is appropriately indicated and provides a diagnostic yield comparable to that requested by specialists. In addition, we note the high clinical utility of positive results as judged by the ordering pediatricians. The findings of this study can empower general pediatricians to advocate for expanded CES adoption to improve patient access and shorten their diagnostic odyssey.
在世界各地儿童医院的入院和门诊病人中,遗传性疾病占了很大比例。临床外显子组测序 (CES) 是诊断这些疾病的重要工具,但普通儿科医生并不经常要求进行这种测序。这可能意味着患者错失了更多使用这一强大诊断工具的机会。在我们医院,普通儿科医生可以直接开具 CES 订单。在此背景下,本研究旨在评估普通儿科医生开具 CES 检查单时的适当性及其临床实用性。我们回顾性地查看了本机构普通儿科医生在 2019 年至 2023 年期间开具的所有 CES 检查单,并记录了其适应症和结果。我们对普通儿科医生进行了访谈,通过评估管理、沟通、后续测试和咨询方面的变化,评估 CES 对临床实用性领域的影响。此外,还获得了反馈意见,并评估了普通儿科医生在订购 CES 时面临的障碍。在30个病例中,11个病例(37%)得到了阳性结果(可解释表型的致病变异或可能致病变异),3个病例(10%)和16个病例(53%)分别得到了模棱两可的结果(意义不明的变异)和阴性结果。所有 30 个病例(100%)的适应症都被认为是适当的。所有 11 个阳性病例(100%)都报告了临床实用性。在这一高度近亲繁殖的人群中,生殖咨询的作用非常显著,因为在 11 个阳性病例中发现的所有变异均为常染色体隐性遗传。此外,我们还注意到,根据开具处方的儿科医生的判断,阳性结果具有很高的临床实用性。这项研究的结果可使普通儿科医生有能力倡导扩大 CES 的应用范围,以改善患者的就医条件并缩短诊断时间。